36
Views
6
CrossRef citations to date
0
Altmetric
TECHNICAL NOTE

A genotyping method for VKORC1 1173C>T by Pyrosequencing® technology

, &
Pages 427-430 | Received 02 Oct 2007, Accepted 14 Nov 2007, Published online: 08 Jul 2009

References

  • Stenflo J., Fernlund P., Egan W., Roepstrff. Vitamin K dependent modification of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974; 71: 2730–3
  • Whitlon D. S., Sadowski J. A., Suttie J. W. Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry 1978; 17: 1371–7
  • Rost S., Fregin A., Ivaskevicius V., Conzelmann E., Hortnagel K., Pelz H. J., et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537–41
  • Li T., Chang C. Y., Jin D. Y., Lin P. J., Khvorova A., Stafford D. W. Identification of the gene for vitamin K epoxide reductase. Nature 2004; 427: 541–4
  • Rieder M. J., Reiner A. P., Gage B. F., Nickerson D. A., Eby C. S., McLeod H. L., et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005; 352: 2285–93
  • Geisen C., Watzka M., Sittinger K., Steffens M., Daugela L., Seifried E., et al. VKORC1 haplotypes and their impact on the inter‐individual and inter‐ethnical variability of oral anticoagulation. Thromb Haemost 2005; 94: 773–9
  • D'Andrea G., D'Ambrosio R. L., Di Perna P., Chetta M., Santacroce R., Brancaccio V., et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose‐anticoagulant effect of warfarin. Blood 2005; 105: 645–9
  • Wadelius M., Chen L. Y., Downes K., Ghori J., Hunt S., Eriksson N., et al. Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J 2005; 5: 262–70
  • Yuan H. Y., Chen J. J., Lee M. T., Wung J. C., Chen Y. F., Charng M. J., et al. A novel functional VKORC1 promoter polymorphism is associated with inter‐individual and inter‐ethnic differences in warfarin sensitivity. Hum Mol Genet 2005; 14: 1745–51
  • Osman A., Enstrom C., Arbring K., Soderkvist P., Lindahl T. L. Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records. J Thromb Haemost 2006; 4: 1723–9
  • Hatch E., Sconce E. A., Daly A. K., Kamali F. A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene. J Thromb Haemost 2006; 4: 1158–9
  • Jannetto P. J., Laleli‐Sahin E., Wong S. H. Pharmacogenomic genotyping methodologies. Clin Chem Lab Med 2004; 42: 1256–64
  • Alderborn A., Kristofferson A., Hammerling U. Determination of single‐nucleotide polymorphisms by real‐time pyrophosphate DNA sequencing. Genome Res 2000; 10: 1249–58
  • Ronaghi M., Uhlen M., Nyren P. A sequencing method based on real‐time pyrophosphate. Science 1998; 281: 363–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.